AC Immune SA ACIU
NASDAQ
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -84.67M | -84.66M | -58.48M | -57.96M |
| Total Depreciation and Amortization | -- | 3.02M | 2.80M | 2.65M | 2.50M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 6.47M | 3.89M | 2.45M | 9.60M |
| Change in Net Operating Assets | -- | -8.25M | 21.96M | 3.94M | 96.09M |
| Cash from Operations | -- | -83.43M | -56.01M | -49.43M | 50.23M |
| Capital Expenditure | -- | -1.06M | -1.03M | -1.15M | -775.80K |
| Sale of Property, Plant, and Equipment | -- | 18.20K | 18.20K | 18.20K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 79.18M | 54.76M | 26.69M | -86.47M |
| Cash from Investing | -- | 78.14M | 53.75M | 25.55M | -87.24M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -1.03M | -937.00K | -851.00K | -769.00K |
| Issuance of Common Stock | -- | 7.00K | 7.00K | 3.00K | 135.00K |
| Repurchase of Common Stock | -- | -1.00K | -25.00K | -26.00K | -26.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -1.00K | -1.00K | -30.00K |
| Cash from Financing | -- | -1.23M | -1.13M | -1.01M | -779.90K |
| Foreign Exchange rate Adjustments | -- | -3.30M | -860.00K | -4.01M | -4.12M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -9.82M | -4.25M | -28.91M | -41.91M |